# Biomat USA, Inc. – FDA Inspection, Apr 8, 2010

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e0617a4e-9970-4425-aa2e-65b475098623
Source feed: FDA_Inspections

> FDA inspection 658222 of Biomat USA, Inc., April 08, 2010. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 658222
- Company Name: Biomat USA, Inc.
- Inspection Date: 2010-04-08
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1063917 - 2018-07-24
- [FDA Inspection 984810 - 2016-09-09](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4bedcd6d-3cde-47d9-855b-e30341e0b7b9)
- [FDA Inspection 898284 - 2014-09-26](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/9511027d-7098-4db1-b021-6e6e10c71604)
- FDA Inspection 800555 - 2012-09-19

Company: https://www.keypedia.com/companies/biomat-usa-inc/7ffb9728-73eb-4e4b-b8db-995e6532e794

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d